FrancophonIA/ELRC3.0 huggingface dataset:
English: Acute GVHD was rated as serious in 3 patients.
Estonian: Ägedat transplantaat-peremehe-vastu reaktsiooni peeti tõsiseks 3 patsiendi puhul.
English: *veno occlusive liver disease is more frequent in paediatric population.
Estonian: *maksa veene okluseeriv haigus on sagedasem lastel **teatatud turustamisjärgselt seoses i.v.
English: Busulfan must not be infused concomitantly with another intravenous solution.
Estonian: Busulfan Fresenius Kabi't ei tohi infundeerida koos teiste intravenoossete lahustega.
English: • Quantity of diluent: (A ml Busulfan Fresenius Kabi) x (10) = B ml of diluent To prepare the final solution for infusion, add (A) ml of Busulfan Fresenius Kabi to (B) ml of diluent
Estonian: D: Busulfan Fresenius Kabi annus (vt lõik 4.2) - Lahusti kogus: (A ml Busulfan Fresenius Kabi't) x (10) = B ml lahustit Lõpliku infusioonilahuse valmistamiseks tuleb (A) ml Busulfan Fresenius Kabi't lisada (B) ml lahustile (kas 9 mg/ml (0,9%) naatriumkloriidi süstelahusele või 5% glükoosi süstelahusele).
English: Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion Busulfan
Estonian: Busulfan Fresenius Kabi 6 mg/ml infusioonilahuse kontsentraat busulfaan
English: Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion busulfan
Estonian: Busulfan Fresenius Kabi 6 mg/ml infusioonilahuse kontsentraat Busulfaan
English: Transaminases increased
Estonian: Kehakaalu tõus
English: Blood urea increased GGT increased
Estonian: Kusihappe tõus veres Uurea tõus veres GGT tõus
English: For any information about this medicine, please contact the Marketing Authorisation Holder This leaflet was last revised in {MM/YYYY} Other sources of information
Estonian: Lisaküsimuste tekkimisel selle ravimi kohta pöörduge palun müügiloa hoidja poole.
English: CARTON containing 1 vial
Estonian: SISEPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED KARP, mis sisaldab 1 viaali
English: When diluted Busulfan Fresenius Kabi is a clear colourless viscous solution.
Estonian: Lahjendatud Busulfan Fresenius Kabi on selge värvitu viskoosne lahus.
English: Busulfan Fresenius Kabi in combination with cyclophosphamide: - The recommended dose of Busulfan Fresenius Kabi is 0.8 mg/kg
Estonian: Busulfan Fresenius Kabi kombineeritud kasutus tsüklofosfamiidiga: - Soovitatav Busulfan Fresenius Kabi annus on 0,8 mg/kg - Iga infusioon kestab 2 tundi.
English: Read this guide prior to the preparation and administration of Busulfan Fresenius Kabi.
Estonian: Enne Busulfan Fresenius Kabi valmistamist ja manustamist lugege käesolevat juhendit.
English: Diluted Busulfan Fresenius Kabi is a clear colourless solution.
Estonian: Lahjendatud Busulfan Fresenius Kabi on selge värvitu lahus.
English: (sodium chloride 9 mg/ml (0.9%) solution for injection or glucose solution for injection 5%).
Estonian: mis ei sisalda 9 mg/ml (0,9%) naatriumkloriidi süstelahust või 5% glükoosi süstelahust.
English: Preparation of Busulfan Fresenius Kabi Procedures for proper handling and disposal of anticancer medicinal products should be considered.
Estonian: 6.6 Erihoiatused ravimpreparaadi hävitamiseks ja käsitlemiseks Busulfan Fresenius Kabi valmistamine
English: NAME OF THE MEDICINAL PRODUCT Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion
Estonian: RAVIMPREPARAADI NIMETUS Busulfan Fresenius Kabi 6 mg/ml infusioonilahuse kontsentraat
English: Adequate contraceptive precautions should be used when either partner is receiving Busulfan Fresenius Kabi.
Estonian: Kui ükskõik kumb partneritest saab Busulfan Fresenius Kabi't, tuleb kasutada piisavaid rasestumisvastaseid vahendeid.
English: It may no longer be possible for you to achieve a pregnancy (infertility) after treatment with Busulfan Fresenius Kabi.
Estonian: Pärast Busulfan Fresenius Kabi'ga ravimist ei pruugi teil enam olla võimalik rasestuda.
English: NAME OF THE MEDICINAL PRODUCT Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion busulfan
Estonian: RAVIMPREPARAADI NIMETUS Busulfan Fresenius Kabi 6 mg/ml infusioonilahuse kontsentraat busulfanum
English: Or
Estonian: Mukosiit
English: PROCEDURE FOR PROPER DISPOSAL
Estonian: SOOVITUS OHUTUKS KÄSITSEMISEKS
English: Asthenia Chills
Estonian: Peavalu Pearinglus
English: Women must stop breast-feeding before starting their treatment with Busulfan Fresenius Kabi.
Estonian: Enne ravi alustamist Busulfan Fresenius Kabi'ga peavad naised imetamise lõpetama.
English: Cardiac disorders
Estonian: Südame häired Tahhükardia
English: Hyperventilation Respiratory failure
Estonian: Hingamisseiskus Alveolaarverejoo ksud
English: Oesophagitis
Estonian: Hüpogonadism
English: Gastrointestinal haemorrhage
Estonian: Pigmentatsioonih äire
English: No evidence of an induction effect of phenytoin has been seen on busulfan data.
Estonian: Busulfaani andmed ei ole näidanud fenütoiini krampe esilekutsuvat toimet.
English: - 12 hours after dilution when stored at 2°C-8°C followed by 3 hours stored at 25°C ± 2°C (including infusion time).
Estonian: Pärast lahjendamist 5% glükoosi või 9 mg/ml (0,9%) naatriumkloriidi süstelahuses on lahuse keemilist ja füüsikalist stabiilsust näidatud (kaasa arvatud infusiooni aeg) 8 tundi, säilitades temperatuuril 25°C ± 2°C või 12 tundi pärast lahjendamist, säilitades temperatuuril 2°C…8°C, millele järgneb 3 tundi säilitamist temperatuuril 25°C ± 2°C (kaasa arvatud infusiooni aeg).
English: Asthenia Oedema Pain
Estonian: Rindkere valu Turse
English: Stomatitis Diarrhoea Abdominal pain Nausea
Estonian: Stomatiit Kõhulahtisus Kõhuvalu Iiveldus Oksendamine Düspepsia Astsiit
English: BATCH NUMBER Lot 14.
Estonian: PARTII NUMBER Partii nr:
English: Tabulated lists of adverse reactions
Estonian: Kõrvaltoimete loetelu tabelis
English: This will help protect them against infectious bronchitis.
Estonian: See aitab neid nakkusliku bronhiidi eest kaitsta.
English: For prolonged immunity, chickens should be revaccinated every 6 weeks after the initial administration.
Estonian: Pikaajalise immuunsuse tagamiseks tuleb kanu pärast esmakordset vaktsineerimist iga 6 nädala tagant uuesti vaktsineerida.
English: There are no precautions for the person, but it is recommended to wash and disinfect hands and equipment after vaccinating to avoid spread of the virus.
Estonian: Inimestele ettevaatusabinõusid ei ole, kuid viiruse levitamise vältimiseks on soovitatav pärast vaktsineerimist käed ja töövahendid puhtaks pesta ja desinfitseerida.
English: The vaccine virus may spread from vaccinated to non-vaccinated chickens, so care should be taken to separate vaccinated from non-vaccinated chickens.
Estonian: Vaktsiinis sisalduv viirus võib levida vaktsineeritud kanadelt vaktsineerimata kanadele, seega tuleb vaktsineeritud kanad vaktsineerimata kanadest eraldada.
English: It is also the time allowed after administration of the medicine before eggs may be used for human consumption.
Estonian: See on ka aeg, mis peab ravimi manustamisest mööduma, kuni mune tohib toiduks tarvitada.
English: The main measures of effectiveness included the development of antibodies to the IB 4-91 virus, the overall death rate of the chickens and the percentage of chicken rejected because of disease.
Estonian: Efektiivsuse põhinäitajad olid antikehade tekkimine IB 4-91 viiruse vastu, kanade üldine suremus ning haiguse tõttu vastuvõtmata jäänud kanade protsent.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) agreed that the benefits of Nobilis IB 4-91 exceed the risks for the approved indication and recommended that Nobilis IB 4-91 should be given a marketing authorisation.
Estonian: Veterinaarravimite komitee järeldas, et heakskiidetud näidustusel on Nobilis IB 4-91 kasulikkus suurem kui sellega kaasnevad riskid, ja soovitas anda Nobilis IB 4-91 müügiloa.
English: Avian infectious bronchitis vaccine (live attenuated)
Estonian: lindude nakkusliku bronhiidi vaktsiin (elus, nõrgestatud)
English: The European Commission granted a marketing authorisation valid throughout the European Union for Nobilis IB 4-91 on 9 June 1998.
Estonian: Euroopa Komisjon andis vaktsiini Nobilis IB 4-91 müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 9. juunil 1998.
English: Nobilis IB 4-91 can cause mild respiratory signs of disease which may last for a few days depending on the health and condition of the chickens.
Estonian: Nobilis IB 4-91 võib põhjustada kergeid respiratoorseid haigusnähte, mis võivad püsida olenevalt kanade tervislikust seisundist mõne päeva jooksul.
English: The Nobilis IB 4-91 vaccine has been studied in various vaccination schedules in a number of trials.
Estonian: Vaktsiini Nobilis IB 4-91 kasutamist uuriti mitmes uuringus mitmesugustes vaktsineerimisskeemides.
English: The avian infectious bronchitis virus in Nobilis IB 4-91 has been attenuated (weakened) so that it does not cause disease.
Estonian: Vaktsiinis Nobilis IB 4-91 sisalduv lindude nakkusliku bronhiidi viirus on atenueeritud (nõrgestatud), et see ei põhjustaks haigust.
English: In the future if the animals are exposed to the virus the immune system will be able to respond more quickly.
Estonian: Kui linnud puutuvad hiljem viirusega uuesti kokku, tekivad antikehad kiiremini.
English: In one trial, after three weeks 100% of chickens had developed antibodies to the IB 4-91 virus compared with 17% for the controls.
Estonian: Ühes uuringus olid kolme nädala pärast tekkinud IB 4-91 viiruse antikehad 100%-l kanadest, kuid kontrollrühmas 17%-l kanadest.
English: Nobilis IB 4-91 vaccine has also been compared with controls, i.e. chickens that were not vaccinated.
Estonian: Vaktsiini Nobilis IB 4-91 võrreldi ka kontrollrühmadega, st vaktsineerimata kanadega.
English: Nobilis IB 4-91 is a veterinary vaccine that contains live attenuated (weakened) avian infectious bronchitis virus.
Estonian: Nobilis IB 4-91 on veterinaarvaktsiin, mis sisaldab lindude nakkusliku bronhiidi elus atenueeritud (nõrgestatud) viirust.
English: The withdrawal period for Nobilis IB 4-91 for chickens is zero days.
Estonian: Nobilis IB 4-91 keeluaeg kanade puhul on 0 päeva.
English: Nobilis IB 4-91 is a vaccine.
Estonian: Nobilis IB 4-91 on vaktsiin.
English: Nobilis IB 4-91 can be given to 1-day-old chicks and older chickens by coarse spray or by intranasal (breathed in through the nose) or ocular (absorbed by the eyes) administration.
Estonian: Vaktsiini Nobilis IB 4-91 tohib manustada vähemalt 1-päevastele kanadele jämedatilgalise pihusena või intranasaalselt (nina kaudu sissehingamise teel) või okulaarselt (silmade kaudu imendumise teel).
English: When Nobilis IB 4-91 is given to chickens the animals' immune system recognises the virus as ‘foreign' and makes antibodies against it.
Estonian: Kui kanadele manustatakse vaktsiini Nobilis IB 4-91, peab loomade immuunsüsteem viirust võõraks ja tekitab selle vastu antikehi.
English: The vaccine can be administered to future layers and breeders from day old onwards via intranasal/ocular route or coarse spray.
Estonian: Vaktsiini tohib manustada tulevastele munakanadele ja aretuseks ettenähtud vähemalt 1-päevastele kanadele intranasaalselt või okulaarselt või jämedatilgalise pihusena.
English: The vaccine can be administered to 7-day and older chickens by drinking water.
Estonian: Vähemalt 7-päevastele kanadele tuleb anda vaktsiini koos joogiveega.
English: The vaccine was given by coarse spray to chicken of various ages.
Estonian: Vaktsiini manustati erinevas vanuses kanadele jämedatilgalise pihusena.
English: What is Nobilis IB 4-91?
Estonian: Mis on Nobilis IB 4-91?
English: Nobilis IB 4-91 is used to immunise chickens to reduce the respiratory signs of infectious bronchitis caused by the variant strain IB 4-91, which causes infectious bronchitis in chickens.
Estonian: Nobilis IB 4-91 on ette nähtud kanade nakkusliku bronhiidi respiratoorseid nähte põhjustava nakkusliku bronhiidi viiruse tüve IB 4-91 vastaseks immuniseerimiseks.
English: Why has Nobilis IB 4-91 been approved?
Estonian: Miks Nobilis IB 4-91 heaks kiideti?
English: Other information about Nobilis IB 4-91:
Estonian: Muu teave Nobilis IB 4-91 kohta
English: What is the risk associated with Nobilis IB 4-91?
Estonian: Mis riskid vaktsiiniga Nobilis IB 4-91 kaasnevad?
English: Nobilis IB 4-91 is available as a lyophilisate (freeze-dried powder) which is to be made up into a suspension.
Estonian: Vaktsiini Nobilis IB 4-91 turustatakse suspensiooni lüofilisaadina (külmkuivatatud pulber).
English: How does Nobilis IB 4-91 work?
Estonian: Kuidas Nobilis IB 4-91 toimib?
English: How has Nobilis IB 4-91 been studied?
Estonian: Kuidas vaktsiini Nobilis IB 4-91 uuriti?
English: There was a clear immune response to Nobilis IB 4-91.
Estonian: Vaktsiini Nobilis IB 4-91 suhtes tekkis selge immuunvastus.
English: What is Nobilis IB 4-91 used for?
Estonian: Milleks vaktsiini Nobilis IB 4-91 kasutatakse?
English: 1 bottle + 30 syringes + 1 syringe adapter + 1 carrying case
Estonian: 1 pudel + 30 süstalt + 1 süstla adapter + 1 kandekott
English: EU Number
Estonian: Müügiloa number Euroopa Liidus
English: Oral solution bottle (glass)
Estonian: Suukaudne lahus Suukaudne pudel (klaas)
English: Package size
Estonian: Pakendi iseloomustus Pakendi sisu Pakendi suurus
English: The European Commission granted a marketing authorisation valid throughout the EU for Clopidogrel Qualimed to Qualimed on 23 September 2009.
Estonian: Euroopa Komisjon andis Clopidogrel Qualimedi müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, ettevõttele Qualimed 23. septembril 2009.
English: The standard dose of Clopidogrel Qualimed is one 75 mg tablet once a day, taken with or without
Estonian: Clopidogrel Qualimedi tavaannus on üks 75 mg tablett üks kord ööpäevas koos toiduga või ilma.
English: Clopidogrel Qualimed can be started between seven days and six months after
Estonian: Clopidogrel Qualimedi manustamist võib alustada seitsme päeva kuni kuue kuu jooksul pärast insulti;
English: Clopidogrel Qualimed can be started between a few days and 35 days after the attack;
Estonian: Clopidogrel Qualimedi manustamist võib alustada mõne kuni 35 päeva jooksul pärast infarkti;
English: If you want more information on the basis for the CHMP recommendations, read the Scientific Discussion (also
Estonian: Kui soovite lisateavet inimravimite komitee soovituste aluse kohta, lugege palun teadusliku arutelu kokkuvõtet (samuti Euroopa avaliku hindamisaruande osa).
English: The Committee recommended that Clopidogrel Qualimed be given marketing
Estonian: Komitee soovitas anda Clopidogrel Qualimedi müügiloa.
English: Clopidogrel Qualimed is a ‘generic medicine'.
Estonian: Clopidogrel Qualimed on geneeriline ravim.
English: Because Clopidogrel Qualimed is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as those of the reference medicine.
Estonian: Et Clopidogrel Qualimed on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: The full EPAR for Clopidogrel Qualimed can be found here.
Estonian: Euroopa avaliku hindamisaruande täisteksti Clopidogrel Qualimedi kohta leiate siit.
English: Clopidogrel Qualimed is used in adults to prevent atherothrombotic events (problems caused by blood clots and hardening of the arteries).
Estonian: Clopidogrel Qualimedi kasutatakse aterotrombootiliste nähtude (trombide ehk soonesiseste verehüüvete moodustumisest ja arterite lubjastumisest põhjustatud probleemide) ennetamiseks täiskasvanutel.
English: This means that Clopidogrel Qualimed is similar to a ‘reference medicine' already authorised in the European Union (EU) called Plavix.
Estonian: See tähendab, et Clopidogrel Qualimed on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
English: Clopidogrel Qualimed is a medicine that contains the active substance clopidogrel.
Estonian: Clopidogrel Qualimed on ravim, mis sisaldab toimeainena klopidogreeli.
English: Therefore, the CHMP's view was that, as for Plavix, the benefit outweighs the identified risk.
Estonian: Seetõttu arvas inimravimite komitee, et nagu ka Plavixi korral, ületab Clopidogrel Qualimedi kasulikkus sellega kaasnevad riskid.
English: The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Clopidogrel Qualimed has been shown to have comparable quality and to be bioequivalent to Plavix.
Estonian: Inimravimite komitee otsustas, et vastavalt Euroopa Liidu nõuetele on tõendatud Clopidogrel Qualimedi võrdväärne kvaliteet ja bioekvivalentsus ravimiga Plavix.
English: Clopidogrel Qualimed can be given to the following groups of
Estonian: Clopidogrel Qualimedi võib kasutada järgmiste patsiendirühmade korral:
English: Clopidogrel Qualimed clopidogrel
Estonian: Clopidogrel Qualimed klopidogreel Kokkuvõte üldsusele
English: Because Clopidogrel Qualimed is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Plavix.
Estonian: Et Clopidogrel Qualimed on geneeriline ravim, piirdusid uuringud katsetega, milles näidati Clopidogrel Qualimedi bioekvivalentsust võrdlusravimiga Plavix.
English: Other information about Clopidogrel Qualimed:
Estonian: Muu teave Clopidogrel Qualimedi kohta
English: How has Clopidogrel Qualimed been studied?
Estonian: Kuidas Clopidogrel Qualimedi uuriti?
English: What is Clopidogrel Qualimed used for?
Estonian: Milleks Clopidogrel Qualimedi kasutatakse?
English: What are the benefit and risk of Clopidogrel Qualimed?
Estonian: Milles seisneb Clopidogrel Qualimedi kasulikkus ja mis riskid ravimiga kaasnevad?
English: Why has Clopidogrel Qualimed been approved?
Estonian: Miks Clopidogrel Qualimed heaks kiideti?
English: The active substance in Clopidogrel Qualimed, clopidogrel, is an inhibitor of platelet aggregation.
Estonian: Clopidogrel Qualimedi toimeaine klopidogreel on trombotsüütide agregatsiooni (vereliistakute kokkukleepumise) inhibiitor, mis aitab ennetada organismis trombide tekkimist.
English: Not known (cannot be estimated from the available data)
Estonian: Teadmata (ei ole võimalik hinnata olemasolevate andmete põhjal)
English: • if you do not realise when you are thirsty
Estonian: • kui ei tunne, kui olete janune,
English: • Take the tablets once a day preferably in the morning with or without food.
Estonian: • Võtke tablette üks kord päevas, eelistatavalt hommikul koos söögiga või ilma.
English: Date of first authorisation: 03 August 2009 Date of latest renewal: 19 June 2014
Estonian: Müügiloa esmase väljastamise kuupäev: 03. august 2009 Müügiloa viimase uuendamise kuupäev: 19. juuni 2014
English: • if you are pregnant
Estonian: • kui olete rase,
English: In particular this applies to patients with inadequately controlled type II diabetes.
Estonian: Eriti kehtib see ebapiisavalt kontrollitud II tüüpi diabeediga patsientide jaoks.
English: For such patients, alternative treatment has to be considered.
Estonian: Selliste patsientide jaoks tuleb kaaluda alternatiivset ravi.
English: Samsca is not suitable for children and adolescents (under age 18).
Estonian: Samsca ei sobi laste ja noorukite jaoks (alla 18-aastased).
English: The efficacy and safety in this population is not well established.
Estonian: Tõhusus ja ohutus selle rühma jaoks ei ole piisavalt kindlaks määratud.
English: Remember to take the medicine pack with you so that it is clear what you have taken.
Estonian: Ärge unustage ravimipakendit kaasa võtta, et oleks selge, mida te manustasite.
English: • Treatment with Samsca will be initiated in hospital.
Estonian: • Ravi Samscaga alustatakse haiglas.
English: • low blood pressure when standing up
Estonian: • madal vererõhk püsti seismisel
English: To monitor the effects of Samsca your doctor will do regular blood tests.
Estonian: Samsca toime jälgimiseks teeb teie arst regulaarselt vereanalüüse.
English: Samsca with food and drink
Estonian: Samsca koos toidu ja joogiga
English: • if you cannot drink enough water or if you are fluid restricted
Estonian: • kui te ei suuda piisavalt vett juua või kui teie vedelikutarbimine on piiratud,
English: Urinary output must be secured.
Estonian: Uriini väljutus peab olema tagatud.
English: Consequently, the frequency of these adverse reactions is qualified as "not known".
Estonian: Seega liigitatakse nende kõrvaltoimete sagedus kui „teadmata“.
English: Therefore, patients must have access to water and be able to drink sufficient amounts of water.
Estonian: Seetõttu peab vesi olema patsientidele kättesaadav ning nad peavad olema suutelised jooma piisavaid veekoguseid.
English: However, you may occasionally feel dizzy or weak or you may faint for a short period.
Estonian: Võite siiski tunda aeg-ajalt pearinglust või nõrkust või lühiajaliselt minestada.
English: If you notice any of the following side effects, you may need urgent medical attention.
Estonian: Kui märkate ühte järgmistest kõrvaltoimetest, võite vajada kohest arstiabi.
English: Do not take this medicine if you are pregnant or breast-feeding.
Estonian: Ärge võtke seda ravimit, kui olete rase või toidate rinnaga.
English: If you forget to take your medicine you have to take the dose as soon as you remember on the same day.
Estonian: Kui te unustate oma ravimit võtta, peate võtma annuse samal päeval kohe, kui see meelde tuleb.
English: That can lead to difficulties in concentration and memory, or in keeping your balance.
Estonian: See võib põhjustada raskusi keskendumisel, meelespidamisel või tasakaalu hoidmisel.
English: Other medicines and Samsca
Estonian: Muud ravimid ja Samsca
English: • other products which increase the salt in your blood or which contain large amounts of salt.
Estonian: • muud ravimid, mis tõstavad vere soolasisaldust või sisaldavad palju soola.
English: The safety and efficacy of tolvaptan in children and adolescents under the age of 18 years have not yet been established.
Estonian: Tolvaptaani ohutus ja efektiivsus lastel ja noorukitel vanuses kuni 18 aastat ei ole veel tõestatud.
English: Administration preferably in the morning, without regard to meals.
Estonian: Manustada eelistatavalt hommikul söögiaegadele vaatamata.
English: • rifampicin (against tuberculosis).
Estonian: • rifampitsiin (tuberkuloosi vastu).
English: • if your kidneys do not work (no urine production)
Estonian: • kuid teie neerud ei tööta (puudub uriinieritus),
English: It is therefore important that you have access to water and that you are able to drink sufficient amounts when you feel thirsty.
Estonian: Seetõttu on oluline, et vesi on teile kättesaadav ja et janu tekkimisel saaksite juua piisavas koguses.
English: Tolvaptan is only a minor component in plasma (3 %).
Estonian: Tolvaptaan on kõigest üks väiksemaid plasmakomponente (3 %).
English: If you do not take your tablet on one day, take your normal dose on the next day.
Estonian: Kui teil jäi ühel päeval tablett võtmata, võtke järgmisel päeval oma tavaline annus.
English: Contents of the pack and other information What Samsca contains
Estonian: Pakendi sisu ja muu teave Mida Samsca sisaldab
English: Tolvaptan was superior to placebo (p < 0.0001) for both periods in both studies.
Estonian: Tolvaptaan ületas platseebot (p < 0,0001) mõlema ajavahemiku jaoks mõlemas uuringus.
English: Lactose and galactose intolerance
Estonian: Laktoosi ja galaktoosi talumatus
English: This medicine may lower the effect of the following medicines: • desmopressin (used to increase blood clotting factors).
Estonian: See ravim võib vähendada järgnevate ravimite toimet: • desmopressiin (kasutatakse vere hüübimisfaktorite hulga suurendamiseks).
English: Even though this increase has no clinical relevance, it indicates tolvaptan can potentially increase exposure to CYP3A4 substrates.
Estonian: Kuigi see tõus ei ole kliiniliselt oluline, näitab see, et tolvaptaan võib potentsiaalselt suurendada ekspositsiooni CYP3A4 substraatide suhtes.
English: Tablets must be swallowed without chewing with a glass of water.
Estonian: Tabletid tuleb neelata ilma närimata koos klaasi veega.
English: In the setting of hyponatremia, the treatment duration is determined by the underlying disease and its treatment.
Estonian: Hüponatreemia korral on ravi kestus määratud põhihaiguse ja selle raviga.
English: Drinking enough water
Estonian: Piisava koguse vee joomine
English: The following medicines may increase the effect of this medicine:
Estonian: Järgnevad ravimid võivad suurendada selle ravimi toimet: